Streetbeat News

Revenues

A

Analysts have mixed views on Agilent Technologies (NYSE:A), with recent ratings showing a shift towards more neutral and lower price targets. The average 12-month price target has decreased by 3.75% to $141.0. Despite revenue challenges, Agilent maintains strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 8:02 pm

SCHW

Charles Schwab (NYSE:SCHW) has outperformed the market over the past 20 years with an average annual return of 10.88%, resulting in a $100 investment growing to $786. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 8:01 pm

AGI

Alamos Gold (NYSE:AGI) has outperformed the market over the past 5 years, delivering an average annual return of 21.77%. A $100 investment in AGI 5 years ago would be worth $258.43 today. The company currently has a market capitalization of $6.22 billion.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 8:01 pm

CEG

D

DUK

EVRG

GOOGL

MSFT

PEG

The rapid development of AI by big tech companies is causing significant environmental concerns, including increased energy and water consumption. Companies like Alphabet, Amazon, and Microsoft are driving up demand for data center power, which is straining energy providers like Dominion Energy. Coal and nuclear energy companies are seeing increased demand as a result. Microsoft is also working on a nuclear fusion generator to reduce AI-related carbon emissions by 2028.

Portfolio Pulse from Hayden Buckfire

June 25, 2024 | 7:55 pm

CCL

NCLH

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) shares are trading higher due to sector-wide optimism following Carnival Corporation’s (NYSE:CCL) strong earnings report. Carnival reported a smaller-than-expected loss and higher-than-expected revenue, boosting sentiment across the cruise industry. Increasing vaccination rates and easing travel restrictions are also contributing to the positive outlook.

Portfolio Pulse from Vaishali Prayag

June 25, 2024 | 7:50 pm

CRSP

NTLA

Intellia Therapeutics presented data showing that a 55 mg dose of NTLA-2001 led to a 90% median reduction in serum TTR at day 28 in patients, demonstrating the potential for redosing with in vivo CRISPR therapy. The dose was well tolerated across all patients, indicating a potential advantage for future therapies.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 7:32 pm

RPM

RPM International (NYSE:RPM) has outperformed the market over the past 20 years with an average annual return of 10.41%, surpassing the market by 2.22%. A $1000 investment in RPM 20 years ago would be worth $7,169.64 today. The article highlights the significance of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 7:31 pm

SFM

Sprouts Farmers Market (NASDAQ:SFM) has significantly outperformed the market over the past 5 years, delivering an average annual return of 34.93%. A $1000 investment in SFM 5 years ago would be worth $4,371.10 today. The company's current market capitalization is $8.30 billion.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 7:31 pm

SGBX

Safe & Green Holdings shares are trading higher after the company announced an expanded agreement to manufacture seven additional container-based electrical distribution centers for a client.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 7:27 pm

MSFT

Blizzard, a subsidiary of Microsoft Corp. (NASDAQ:MSFT), has announced the second Public Test Realm (PTR) for Diablo 4, focusing on Season 5. The PTR will run from June 25 to July 2, allowing players to test updates and features before the official release. The new questline leads into the upcoming expansion, Vessel of Hatred, launching on Oct. 8, 2024. Season 5 will introduce new Legendaries, Uniques, and items, along with quality-of-life updates for endgame bosses.

Portfolio Pulse from Franca Quarneti

June 25, 2024 | 7:25 pm